Download IMPROVE Clinical Study

IMPROVE Clinical Study
Objective: Determine the impact of a revolutionary ADC system
on medication distribution and administration variables.
Key Finding: Omnicell solutions are clinically proven to reduce the
delivery time of IV antibiotics to patients at a single-center study
conducted at Hackensack University Medical Center.
Type of Retrospective
Study
Comparison
Primary Endpoint 1
6-month
timeframe
Primary Endpoint 2
Secondary Endpoint
Reduce time to first dose
of a time-critical
antibiotic (PiperacillinTazobactam) by 10%
compared to previous
ADC system.
Reduce time from
scheduled dose to
administration of all IV
antibiotics by 10%
compared to previous
ADC system.
Evaluate number of
in-basket messages
related to missing
medications compared
to previous ADC system.
Outcome:
Outcome:
Outcome:
40.00% reduction
(average of 9 minutes)
The
Omnicell
platform
evaluated
included:
Study Areas
17.68% reduction
13.34% reduction
(average 13 minutes)
label
Single dose
dispensing
without
countbacks
Integrated
medication label
printer
Med-Surgical
Day1
Day2
Day3
Day4
Remote
medication
management
Orthopedics
Automated
patient
medication
management
Oncology
MAS-NAS Survey - 122 nurses rated Omnicell higher than the previous
ADC system in the following categories.
2x
Efficiency of medication administration
Effectiveness in reducing and preventing medication errors
1.6x
Ease of checking active medication orders before administering medications
1.5x
Drug alert feature
1.5x
Availability of information on drug actions and possible side effects
1.5x
Availability of information on how to treat adverse reactions from medications
1.5x
The medication administration time for antibiotics is critically important for the
prevention of infection and the prompt treatment of infection, and is also
regulated by CMS.